Experimental cell therapy targets Tough-to-Treat blood cancer
Disease control
Terminated
This study aimed to test the safety and early effectiveness of an experimental cell therapy called CD7 CAR-T for people with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. The therapy involved collecting a patient's own immune cells, modif…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC